Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 60

Results For "market"

4294 News Found

Pharma stocks face Q4 reality check amid global headwinds
News | April 20, 2026

Pharma stocks face Q4 reality check amid global headwinds

Analysts expect modest revenue growth but pressure on profitability in the March quarter


Vision Engineering appoints Harry Curtis as Technical Director, joins Board
People | April 20, 2026

Vision Engineering appoints Harry Curtis as Technical Director, joins Board

In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy


Neuland Laboratories elevates Saradhi Bolli to Global Head of CDMO Business Development
People | April 20, 2026

Neuland Laboratories elevates Saradhi Bolli to Global Head of CDMO Business Development

Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services


Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study
Biotech | April 20, 2026

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols


Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
News | April 20, 2026

Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities

PMDA is regarded among the most stringent regulatory bodies globally


Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network
Hospitals | April 20, 2026

Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network

The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.


Takara Bio and Resistomap forge deal to speed up global fight against superbugs
News | April 19, 2026

Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe